These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19601088)

  • 1. An Examination into the Value of Certain Antiseptics Used for the Preservation of Antitoxic and Other Immune Serums.
    McFarland J
    Public Health Pap Rep; 1902; 28():506-8. PubMed ID: 19601088
    [No Abstract]   [Full Text] [Related]  

  • 2. [Purification and enzymatic disantigenization of antitoxic serums and plasmas. III. Theoretical evaluation of antitoxic and anaphylactic function of antitoxic serums and plasmas].
    CORDON F; MARTINEZ A
    Microbiol Esp; 1957; 10(1):69-98. PubMed ID: 13464448
    [No Abstract]   [Full Text] [Related]  

  • 3. [Research on gas gangrene immunity; comparative value of antiperfringent serums of the antitoxic type and of the mixed antitoxic-antibacterial type].
    FREDETTE V; FRAPPIER A
    Rev Can Biol; 1946; 5(4):428-35. PubMed ID: 20291005
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the antitoxic power of anti-perfringens A serums; history].
    GUILLAUMIE M; KREGUER A; GEOFFROY M
    Ann Inst Pasteur (Paris); 1956 Mar; 90(3):265-75. PubMed ID: 13327474
    [No Abstract]   [Full Text] [Related]  

  • 5. [CONTRIBUTION TO THE PROBLEM OF DETERMINATION OF THE DEGREE OF DESPECIATION OF PURIFIED ANTITOXIC SERUMS].
    SZEGLI G; TOMA E; GARTNER M
    Arch Roum Pathol Exp Microbiol; 1963 Sep; 23():791-6. PubMed ID: 14165862
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the antitoxic power of anti-perfringens B, C & D type serums. I. Properties of toxins used to titrate these immune sera].
    GUILLAUMIE M; KREGUER A; GEOFFROY M; VENTRE F
    Rev Immunol Ther Antimicrob; 1957; 21(4):293-309. PubMed ID: 13506328
    [No Abstract]   [Full Text] [Related]  

  • 7. [Azo-binding of antitoxic immune sera. III. Azo-proteins].
    ZIMMERMANN G
    Z Immun exp ther; 1958 Sep; 116(3):219-27. PubMed ID: 13604524
    [No Abstract]   [Full Text] [Related]  

  • 8. [Electro- and immunophoretic study of antitoxic sera].
    EFIMOVA NP; MAL'TSEVA ZI; LOSEVA TA; ALEKSAN-DROVSKAIA LA
    Zh Mikrobiol Epidemiol Immunobiol; 1961 Jan; 32():77-81. PubMed ID: 13725877
    [No Abstract]   [Full Text] [Related]  

  • 9. [Contribution to the study of the relation between serum properdin and pyrogenic substances from purified antitoxic serums].
    Toma E; Szégli G; Gartner M; Negut M
    Arch Roum Pathol Exp Microbiol; 1964 Dec; 23(4):967-72. PubMed ID: 5836099
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect pf antitoxic serum in experimental tetanus].
    CHERNAIA LA; SAMODELKINA EN; KAPLINA ZI
    Zh Mikrobiol Epidemiol Immunobiol; 1954 Aug; 8():53-8. PubMed ID: 13206347
    [No Abstract]   [Full Text] [Related]  

  • 11. [Purification and concentration of antitoxic plasmas. I. History, technics in industry and method used in Iran].
    DELSAL JL; CHAMSY HM
    Rev Immunol Ther Antimicrob; 1953; 17(3):110-34. PubMed ID: 13089273
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antitoxic power of types B and C antiperfringens serums].
    GUILLAUMIE M; KREGUER A; GEOFFROY M; VENTRE F
    C R Hebd Seances Acad Sci; 1957 Jul; 245(2):245-8. PubMed ID: 13461392
    [No Abstract]   [Full Text] [Related]  

  • 13. [Purification of antitoxic serums].
    AMOUREUX G; YEU F
    Ann Inst Pasteur (Paris); 1951 Feb; 80(2):165-74. PubMed ID: 14829892
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitoxic Serums.
    Houghton EM
    Buffalo Med J; 1898 Jul; 37(12):881-891. PubMed ID: 36887985
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clarification of therapeutic and immunogenic values of sero-antitoxic therapy of tetanus].
    KATIC R
    Vojnosanit Pregl; 1960 Mar; 17():229-35. PubMed ID: 14404721
    [No Abstract]   [Full Text] [Related]  

  • 16. [SORPTION OF ANTITOXIC ANTIGANGRENE SERUM WITH HUMAN ERYTHROCYTES].
    SINADSKII NE
    Zh Mikrobiol Epidemiol Immunobiol; 1963 May; 40():121-3. PubMed ID: 14077123
    [No Abstract]   [Full Text] [Related]  

  • 17. [Elimination of pyogenic substances from purified an concentrated antitoxic serums].
    SZEGLI G; TOMA E; STANICA E; STOIAN C; GARTNER M
    Arch Roum Pathol Exp Microbiol; 1962 Mar; 21():163-70. PubMed ID: 13979895
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative Antitoxic and Antitanolytic Titers Of Various Normal Serums].
    LEMETAYER E; NICOL L
    C R Seances Soc Biol Fil; 1945 Jul; 139():622. PubMed ID: 21023429
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of ion-exchange resins in desalting of fermented antitoxic sera during their purification and concentration].
    SHAKHANINA KL
    Zh Mikrobiol Epidemiol Immunobiol; 1959 Jul; 30():105-9. PubMed ID: 14445407
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of phenol and of the temperature in thermal denaturation on purification and concentration of antitoxic sera using the method of fermentative hydrolysis].
    MIKHAILOV AI; ROGOZINA EN
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Aug; 27(8):83-7. PubMed ID: 13393662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.